[{"Assets_0_Q2_USD":32641000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1638000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1636000000.0,"StockholdersEquityConverted_0_Q2_USD":12418000000.0,"StockholdersEquity_0_Q2_USD":12317000000.0,"RevenuesConverted_2_Q2_USD":10433000000.0,"RevenuesConverted_1_Q2_USD":5461000000.0,"NetIncomeLossConverted_2_Q2_USD":1859000000.0,"NetIncomeLossConverted_1_Q2_USD":373000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":2232000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.13,"EarningsPerShareDiluted_1_Q2_USD":0.23,"EarningsPerShareBasic_2_Q2_USD":1.14,"EarningsPerShareBasic_1_Q2_USD":0.23,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.8,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.4,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1633000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1633000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180726"}]